Nanophage Technologies. Creating the science of the future, now.

 
 

In 2014, Stephen Hawking’s programme, The Science of the Future, featured filament-like viruses as a future technology. Associate Professor Jasna Rakonjac of Massey University’s School of Natural Sciences wholeheartedly agrees. 

Jasna has dedicated 10 years developing a safer virus-free production of biological nanorods and is now applying this novel technology to develop a first-to-market diagnostic test through the start-up company Nanophage Technologies Ltd.

 
Electron microscope image of the stacked 80-nm nanorods

Electron microscope image of the stacked 80-nm nanorods

Biological nanorods are nanometre-size rods made of DNA and protein. Created in a lab and without using a virus, they are safe for both environmental and human use. The rods’ length can be tuned precisely, and they can be ‘decorated’ with a multitude of antibodies and molecules that allow them to be visualised as brightly coloured probes. Combining these features with the fact that they are inexpensive to manufacture, producing ten quadrillion per batch, these versatile nanorods can be applied in a variety of medical and environmental diagnostic tests quickly, cheaply, and most importantly with high sensitivity.

‘’Biological nanorods will transform diagnostic testing as they have potential to detect the presence of molecules at a far lower levels than other diagnostic tools on the market allowing for early action or medical intervention.’’

- Dr Rakonjac

 

The technology has been developed with support from the Ministry of Business, Innovation and Employment (MBIE) and Massey Ventures Limited, the wholly owned commercialisation company of Massey University. The path to commercialisation is being funded from Callaghan Innovation’s Deep Tech Incubator Programme that supports deep tech start-ups with repayable grants, alongside seed investment from Bridgewest Ventures.

“Bridgewest are focused on incubating and launching major, global, innovation-led companies to impact the health industry. Biological nanorods will power the next generation of diagnostics and create the change we want to see.”

- Saum Vahdat, Managing Partner of Bridgewest Ventures and Director of Nanophage Technologies

 

 

Do you have the next big idea in deep tech?

We’re searching for meaningful innovations that will impact our world socially, economically, or environmentally. This can come in many forms, from technology advances in AI development and semiconductor engineering to life science breakthroughs or biomedical discovery.

If you’ve got a novel idea, apply to the Bridgewest Ventures Deep Tech Incubator today!

Previous
Previous

Using breakthrough nanorod technology as a novel approach to diagnostics

Next
Next

Alexandra Galbon on how chemical R&D skills span industries